Laxmi Dental Share Price

Extract of newspaper advertisements published on August 13, 2026, in the Financial Express (English Newspaper) and Mumbai Lakshdeep (Marathi Newspaper), with respect to Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, approved by the Board of Directors at its meeting held on Tuesday, August 11, 2026.

• BSE India
• 4 days 13 hours ago

Q1FY27 Earnings Conference Call Recordings

• BSE India
• 5 days 12 hours ago

<h3><span style="font-size:16px;"><strong>Healthcare Supplies company Laxmi Dental announced Q1FY27 results</strong></span></h3> <p _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Consolidated Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Total Income:</strong> For Q1FY27, the company reported a total income of Rs 769.94 million, representing a YoY increase of 14.37% compared to Rs 673.19 million in Q1FY26 and a marginal QoQ growth of 0.89% from Rs 763.14 million in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Revenue from Operations:</strong> Revenue stood at Rs 746.96 million in Q1FY27, registering a YoY growth of 13.87% from Rs 655.97 million in Q1FY26 and a QoQ increase of 1.00% from Rs 739.54 million in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Profit Before Tax (PBT):</strong> The company achieved a PBT of Rs 120.41 million in Q1FY27, marking a YoY increase of 25.49% from Rs 95.95 million in Q1FY26 and a QoQ growth of 8.14% from Rs 111.35 million in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Net Profit:</strong> Net profit for the period (Profit for the period/year) reached Rs 103.15 million in Q1FY27, up 23.83% YoY from Rs 83.30 million in Q1FY26 and up 2.19% QoQ from Rs 100.94 million in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Earnings Per Share (EPS):</strong> Basic and Diluted EPS for Q1FY27 stood at Rs 1.87, compared to Rs 1.53 in Q1FY26 and Rs 1.83 in Q4FY26.</li> </ul> <p _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Standalone Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Total Income:</strong> Standalone total income for Q1FY27 was Rs 569.13 million, showing a YoY growth of 9.93% from Rs 517.74 million in Q1FY26, while recording a QoQ decline of 1.41% from Rs 577.26 million in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Revenue from Operations:</strong> Standalone revenue was Rs 552.00 million in Q1FY27, representing a YoY increase of 10.15% from Rs 501.13 million in Q1FY26 and a QoQ decrease of 0.96% compared to Rs 557.36 million in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Profit Before Tax (PBT):</strong> Standalone PBT stood at Rs 70.55 million in Q1FY27, a YoY decrease of 21.58% from Rs 89.96 million in Q1FY26, but a QoQ growth of 7.20% from Rs 65.81 million in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Net Profit:</strong> Standalone net profit for the quarter was Rs 61.71 million, down 21.48% YoY from Rs 78.59 million in Q1FY26 and down 9.22% QoQ from Rs 67.98 million in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Earnings Per Share (EPS):</strong> Standalone Basic and Diluted EPS for Q1FY27 was Rs 1.12, against Rs 1.43 in Q1FY26 and Rs 1.24 in Q4FY26.</li> </ul> <p _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Business Highlights:</strong></p> <ul _ngcontent-ng-c1940132427=""> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Segment-wise Performance:</strong> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Laboratory Business:</strong> This segment, comprising dental prosthetic products and laboratory equipment, generated revenue of Rs 502.81 million in Q1FY27, compared to Rs 445.94 million in Q1FY26. The segment result for Q1FY27 was Rs 76.98 million.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Aligners Business:</strong> This segment, which includes dental aligners and related raw materials, recorded revenue of Rs 241.69 million in Q1FY27, up from Rs 187.26 million in Q1FY26. The segment result showed significant growth, reaching Rs 65.33 million in Q1FY27 compared to Rs 22.79 million in Q1FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Other Business:</strong> This segment, comprising dental distribution products and clinical services, reported revenue of Rs 10.43 million in Q1FY27. It achieved a segment result of Rs 1.32 million, recovering from a loss of Rs 5.25 million in Q1FY26.</li> </ul> </li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Strategic Land Acquisition:</strong> The company noted the execution of a Letter of Intent (LOI) to acquire land in Palghar, Maharashtra, for a total consideration of Rs 6,21,00,000 (Rs 6 crore 21 lakh) for the expansion of business operations and construction of a factory.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Utilization of IPO Proceeds:</strong> As of June 30, 2026, the company has utilized Rs 779.72 million out of the total Rs 1,281.70 million raised through its Initial Public Offer (IPO). Key utilizations include Rs 229.84 million for repayment/prepayment of outstanding borrowings and Rs 157.19 million for capital expenditure requirements for new machinery.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">ESOP Allotment:</strong> The Board approved the allotment of 59,360 equity shares of face value Rs 2 each to eligible employees following the exercise of options under the Laxmi Dental Stock Option Scheme 2024.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Merger Update:</strong> The Board has approved a Scheme of Merger for Bizdent Devices Private Limited, a wholly owned subsidiary, with Laxmi Dental Limited. The scheme is currently awaiting regulatory approvals.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Business Rationalization:</strong> During FY26, the Group discontinued the business operations of its subsidiary, Rich Smile Design LLP, as part of a strategic decision.</li> </ul> <p><strong>Rajesh Khakhar, Chairperson and Whole-Time Director, said:</strong> “We are pleased to report a strong start to FY27, with Q1 revenue reaching our highest-ever quarterly level of around Rs 75.0 crore, representing year-on-year growth of 13.9%. The performance was broad-based, led by healthy momentum in our Dental Laboratory business and our Aligner Solutions business. Our profitability during the quarter witnessed some improvement largely on account of a better product mix.</p> <p>We are strengthening our on-ground leadership presence in the U.S. to sharpen our market-focused strategy and sustain healthy growth in this market. In India, we have established 3 new support facilities across multiple cities to deepen our regional presence, enhance market penetration and provide better service to our existing dental partners.</p> <p>Going forward, a focus on core dental portfolio, deeper market penetration, AI-led automation, and improving operational efficiencies enables Laxmi Dental to deliver healthy and sustainable performance.”</p> <p><strong>Sameer Merchant, Managing Director & CEO, said:</strong> “Our robust performance in Q1FY27 reflects the sustained efforts of our sales and operations teams, supported by scanner deployments in the past, training programs, promotional activities, participation in dental events and digital initiatives.</p> <p>For the quarter our dental laboratory business grew by 23.5% YoY, with international operations registering particularly strong growth of 37.4%, reflecting our relationships and market presence across global markets.</p> <p>Aligner Solutions business also maintained its momentum, growing 28.6% year-on-year, with both Bizdent and Vedia delivering healthy growth of 27.8% and 29.3% respectively.</p> <p>With continued progress in digitalization, innovation, branding and dental network expansion, we remain well positioned to deliver sustainable and profitable growth for the upcoming years.”</p> <p><a class="lb" href="/get-document/post/pdf/5781170/" target="_blank">Result PDF</a></p>

• Trendlyne
• 6 days 8 hours ago